---
title: CereGate
date: 2020-01-23T11:17:29Z
modified: 2026-08-13T09:43:29Z
permalink: "https://www.htgf.de/en/portfolio/htgffamily/ceregate/"
type: portfolio
status: publish
excerpt: ""
wpid: 75443
language:
  - English
post_translations:
  - pll_5e2845fcb5176
branchen22:
  - Neuromodulation
sectors:
  - MedTech
focus_areas:
  - Neurology
  - Neuromodulation
timestamp: 2026-08-13T09:43:29Z
tags:
  - English
  - pll_5e2845fcb5176
  - Neuromodulation
  - MedTech
  - Neurology
---

## Beschreibungstext

CereGate is developing a Computer-Brain-Interface (“BCI”) platform that is already capable to successfully submit information into the human brain. The revolutionary software platform is clinically validated and allows for enhanced treatment of various neurological and psychiatric disorders. The CereGate platform is able to transmit information into the brain („Mind-Writing“), by utilizing state of the art neuromodulation technology. While focusing first on improving gait symptoms for Parkinson patients, CereGate aims to become a key enabling tech¬nology in the field of rehabilitation and (neuro)prosthetics.

## Unternehmenswebsite

https://www.ceregate.com/

## Adresse

CereGate GmbH
Große Reichenstraße 27
20457 Hamburg
Germany

## Kontakt

Array

Array